These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23456403)

  • 1. Drug rash with eosinophilia and systemic symptoms syndrome associated with use of phenytoin, divalproex sodium, and phenobarbital.
    Brizendine CE; Naik PJ
    Am J Health Syst Pharm; 2013 Mar; 70(6):507-10. PubMed ID: 23456403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DRESS syndrome: the great clinical mimicker.
    Fleming P; Marik PE
    Pharmacotherapy; 2011 Mar; 31(3):332. PubMed ID: 21361742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a case report from the emergency department.
    Oelze LL; Pillow MT
    J Emerg Med; 2013 Jan; 44(1):75-8. PubMed ID: 21852061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen.
    Yun SJ; Lee JB; Kim EJ; Quan G; Kim SJ; Won YH; Lee SC
    Acta Derm Venereol; 2006; 86(3):241-4. PubMed ID: 16710584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRESS Syndrome Presents as Leukoencephalopathy.
    Tonekaboni SH; Jafari N; Chavoshzadeh Z; Shamsian BS; Rezaei N
    Turk J Pediatr; 2015; 57(5):541-4. PubMed ID: 27411428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.
    Roquin G; Peres M; Lerolle N; Dib N; Mercat A; Croue A; Augusto JF
    Ann Pharmacother; 2010 Dec; 44(12):1998-2000. PubMed ID: 21098750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms.
    Wongkitisophon P; Chanprapaph K; Rattanakaemakorn P; Vachiramon V
    Acta Derm Venereol; 2012 Mar; 92(2):200-5. PubMed ID: 22002792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.
    Gómez-Zorrilla S; Ferraz AV; Pedrós C; Lemus M; Peña C
    Ann Pharmacother; 2012; 46(7-8):e20. PubMed ID: 22764327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome: A Clinical Case Report.
    Varghese A; Alosious A; Thomas R; Surendran K; Vilapurathu JK
    J Pharm Pract; 2024 Feb; 37(1):225-228. PubMed ID: 35924976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.
    Hyser E
    J Med Case Rep; 2022 Sep; 16(1):336. PubMed ID: 36059007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin-induced hypersensitivity reactions.
    Prosser TR; Lander RD
    Clin Pharm; 1987 Sep; 6(9):728-34. PubMed ID: 3677571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.
    Myers AP; Watson TA; Strock SB
    Pharmacotherapy; 2015 Mar; 35(3):e9-e12. PubMed ID: 25756365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypersensitivity syndrome caused by phenytoins and phenobarbital].
    Fonseca JC; Azulay DR; Rozembau I; Azulay RD
    Med Cutan Ibero Lat Am; 1984; 12(3):187-92. PubMed ID: 6237236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross-hypersensitivity syndrome between antiepileptic drugs: report of a case].
    Allende Bandrés MA; Izuel Rami M; Urbieta Sanz E; Villar Fernández I; Carcelén Andrés J
    Farm Hosp; 2004; 28(1):56-8. PubMed ID: 15012179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
    Lunde JL; Nelson RE; Storandt HF
    Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfasalazine-induced DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms).
    Aquino RT; Vergueiro CS; Magliari ME; de Freitas TH
    Sao Paulo Med J; 2008 Jul; 126(4):225-6. PubMed ID: 18853032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-aromatic Anticonvulsant (Divalproex Sodium)-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome.
    Dutta P; Das S; Fershko A
    Cureus; 2021 Sep; 13(9):e17860. PubMed ID: 34660064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The drug hypersensitivity syndrome or DRESS syndrome to phenobarbital].
    Lachgar T; Touil Y
    Allerg Immunol (Paris); 2001 Apr; 33(4):173-5. PubMed ID: 11434197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.